Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Medically diagnosed and according to Rotterdam criteria (at least two of the following oligo/anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries)BMI more than 24 kg/m? (Sam S. Obesity and Polycystic Ovary Syndrome. Obes Manag. 2007 Apr;3(2):69-73. doi: 10.1089/obe.2007.0019. PMID: 20436797; PMCID:PMC2861983) Willing to provide informed consent and comply with study protocol.
Exclusion criteria
Exclusion criteria: Use of hormonal medications like oral contraceptives within the last 3 months Pregnant or planning to become pregnant within the study period Any neurological disorders like multiple sclerosis amyotrophic lateral sclerosis Guillain Barre syndrome etc Any systemic disease like liver dysfunction IBD Kidney failure etc Any congenital disorders like Turner Syndrome Congenital Adrenal Hyperplasia Marfan syndrome History of Cancer Diagnosed with other endocrine disorders like thyroid dysfunction Cushing syndrome etc History of any cardiovascular diseases like uncontrolled hypertension unstable angina etc Participation in another clinical trial at present and within the last six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin Resistance Menstrual health Glucose metabolism Plasma Glucose level Hyperandrogenism quality of lifeTimepoint: base line 12 weeks and follow up 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI , Body composition analysis , hip to waist ratioTimepoint: base line 12 weeks and follow up 3 months | — |
Countries
India
Contacts
Department of physiotherapy , School of healthcare and allied sciences ,GD Goenka University